Literature DB >> 3985812

Cholecystokinin and neurotensin gradients in human CSF.

C A Tamminga, P A LeWitt, T N Chase.   

Abstract

In successive samples of human lumbar CSF, concentrations of two neurally active peptides, cholecystokinin (CCK) and neurotensin (NT), were compared with levels of homovanillic acid (HVA), the major metabolite of dopamine. Although HVA values progressively increased between the first and 20th milliliter samples, no significant change occurred in the concentration of either peptide. Thus, lumbar CSF levels of CCK and NT, unlike levels of HVA, may not closely reflect amounts of these peptides in supraspinal CSF or brain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3985812     DOI: 10.1001/archneur.1985.04060040064013

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Neuronal cholecystokinin and schizophrenia: pathogenic and therapeutic studies.

Authors:  C A Tamminga; R L Littman; L D Alphs; T N Chase; G K Thaker; A M Wagman
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Rostral-caudal concentration gradients of histamine metabolites in human cerebrospinal fluid.

Authors:  G D Prell; J K Khandelwal; P A LeWitt; J P Green
Journal:  Agents Actions       Date:  1989-03

3.  The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.

Authors:  Zhimin Li; Mona Boules; Katrina Williams; Joanna Peris; Elliott Richelson
Journal:  Brain Res       Date:  2009-11-27       Impact factor: 3.252

4.  Do concentrations of neurotransmitters measured in lumbar cerebrospinal fluid reflect the concentrations at brain level?

Authors:  A Gjerris; F Gjerris; P S Sørensen; E B Sørensen; N J Christensen; J Fahrenkrug; J F Rehfeld
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.